Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Single Versus Multiple Dose Studies
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Related Experiment Video
Updated: May 13, 2026

Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Advanced MR techniques in multicenter clinical trials.
1VirtualScopics, Inc., Rochester, New York 14625, USA. ashton@virtualscopics.com
Advanced magnetic resonance imaging (MRI) techniques can now be consistently implemented across multiple clinical trial sites. This enables better assessment of targeted therapeutics by measuring changes in tumor microvasculature, overcoming previous limitations.
More Related Videos
Area of Science:
- Radiology
- Oncology
- Clinical Trials
Background:
- Magnetic resonance imaging (MRI) has been used in clinical trials for over 20 years, primarily for subjective interpretation and structural measurements.
- Advanced MR techniques offer superior insights into therapeutic effects, particularly on tumor microvasculature, but have historically faced challenges in multi-site consistency.
Purpose of the Study:
- To review the benefits and drawbacks of incorporating advanced MR techniques into clinical trial protocols.
- To detail the challenges of deploying these advanced techniques across diverse imaging centers.
Main Methods:
- Review of existing literature and clinical trial methodologies.
- Discussion of protocol design, site selection, training, and analysis standardization for advanced MR imaging.
Main Results:
- Advanced MR techniques, such as dynamic contrast-enhanced MRI, can effectively measure changes in tumor blood flow and vascular permeability.
- Recent efforts demonstrate that with meticulous planning and standardization, consistent and high-quality results are achievable across multiple sites, even with complex protocols.
Conclusions:
- Advanced MR techniques are valuable for evaluating targeted therapeutics affecting tumor microvasculature.
- Overcoming implementation challenges is key to leveraging these powerful tools in large-scale clinical trials across various research institutions and community imaging centers.

